Etoxazole, a widely used mite growth
inhibitor, contains
a chiral
center in its chemical structure, resulting in two mirror-image enantiomers.
These enantiomers of etoxazole display significant differences in
biological activity and environmental behavior. In bioassays conducted
against Tetranychus cinnabarinus, it
was observed that S-etoxazole demonstrated approximately 279.63 times
greater activity against mite eggs compared to R-etoxazole, and its
efficacy against adult mites was approximately 5 times higher than
that of R-etoxazole. Furthermore, S-etoxazole was found to be more
potent in inhibiting chitin synthesis. To elucidate the underlying
mechanism for the observed differences in enantiomeric activity, we
conducted metabolism assays using crude enzymes, revealing that R-etoxazole
undergoes metabolism more readily than S-etoxazole. Subsequent molecular
docking and Microscale Thermophoresis (MST) experiments showed that
R-etoxazole exhibits weaker binding affinity to the target protein,
chitin synthase 1, compared to S-etoxazole. This study thus demonstrates
that the differential enantiomeric activity of etoxazole was attributable
to a combination of factors, including detoxification metabolism and
target protein binding.